"Designing Growth Strategies is in our DNA"

Transforming Growth Factor Beta (Tgf-Beta) Inhibitor – Pipeline Review, 2020

Region : Global | Report ID: FBI100903

 

KEY MARKET INSIGHTS

Various clinical studies have demonstrated the role of TGF-Beta family in the development and progression of various conditions including cancer, bone remodeling, and muscular dystrophy among others. Transforming growth factor beta (TGF-Beta) inhibitors are molecules that inhibit the TGF-beta family members. The superfamily of TGF-Beta inhibitors have demonstrated various clinical applications by delaying cancer progression and preventing fibrosis. Various forms of these inhibitors including natural and other soluble forms including monoclonal antibodies are being developed.


TGF-Beta Inhibitor has shown immunosuppressive effects in the malignant tumor by inhibiting the immune cells from the tumors associated with breast cancer, prostate cancer, colon cancer, and basal cell cancer, etc. In 2019, according to the American Cancer Society (ACM), an estimated 268,600 new cases of invasive breast cancer were diagnosed in women globally.


With the growing prevalence of various cancer around the globe and the demand of effective treatment for cancer, various pharmaceutical companies along with various government-funded research organizations have been focusing on developing TGF-Beta Inhibitor molecules and studying the mechanisms of these inhibitory molecules that can be used to treat various cancers. For instance; AVID200 which is being studied by Forbius (Formation Biologics) is currently in phase-1 clinical trials for studying the ambition mechanism of TGFβ Inhibitor in patients with solid tumor malignancies


To know how our report can help streamline your business, Speak to Analyst


At present around 50% of the pipeline candidates for TGF-Beta Inhibitor are in the phase-3 stage. More than half of the studies are sponsored by industry.


Report Description


The report on ‘TGF-Beta Inhibitor – Pipeline Review, 2020’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for TGF-Beta Inhibitor. The report provides a thorough analysis of the distribution of the pipeline products by clinical trial stage, indication, company, therapy area and details such as clinical trial stage, sponsor, description on every product in the pipeline. Products in the preclinical and clinical stage along with dormant & discontinued pipeline candidates are included in the report. The report also covers additional insights such as recent advances in R&D and current market scenario for TGF-Beta Inhibitor.


The report on ‘TGF-Beta Inhibitor – Pipeline Review, 2020, which is built by following a robust research methodology involving primary interviews and desk research, provides a complete overview of the R&D activity and pipeline products to assist companies in developing growth strategies and identifying emerging players.


Report Scope



  • Thorough assessment of the pipeline products by areas such as development stage; route of administration; drug class; indication; sponsor; molecule type and drug target

  • Comprehensive profiles of the pipeline products with details such as company overview; product description; R&D status; development activities; mechanism of action; molecule type; development stage; indications; funding and route of administration

  • Overview of dormant and discontinued pipeline products

  • Key insights in relation to the epidemiology of conditions being treated by the pipeline products and overview of the addressable or current market for the pipeline products

  • Overview of the latest developments; news articles, press releases and relevant conferences


Report Methodology



  • All pipeline reports are built through the analysis of data primarily collected through credible desk research sources. Secondary research is supplemented by interviews conducted with key opinion leaders.

  • Desk research sources includes global and regional clinical trials databases; annual reports, websites, press releases & investor presentations of companies; white papers; news articles; reports published by industry associations; articles/reports published on databases such as NCBI, ResearchGate; internal databases


Reasons to Buy this Report



  • Develop effective growth strategies based on comprehensive overview of the R&D activity and pipeline products for TGF-Beta Inhibitor

  • Identify emerging players or competition in the market based on pipeline products and develop strategies to counter the emergence of these players

  • Identify the focus of leading players in relation to R&D for TGF-Beta Inhibitor

  • Identify potential companies from a partnership or acquisition point of view based on current synergy in R&D activities or strategies to diversify R&D focus to drive growth in business

  • Analyse the reasons behind dormant and discontinued products to make changes in the R&D focus if necessary


    CHOOSE LICENSE TYPE

  • $2050
    $4150
    $6150

Healthcare Clients

Jubilant
abbvie
Galemed
Johnson
Ipsos

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- UGlobal hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X